 |
Medicines Co MDCO (news,
chart,
quote) - MDCO calls active into potential Senate vote
MDCO, a developer Angiomax, a treatment to clear restricted blood vessels near the heart, is recently up 34c to $19.59. Friedman Billings say's "H.R. 6344, "The Responsive Government Act of 2008." with the positive patent relief provisions for the Medicines company (MDCO – not covered) in on the schedule to be "hotlined" through the Senate today." MDCO call option volume of 15,517 contracts compares to put volume of 301 contracts. MDCO July option implied volatility of 68 is above a level of 61 from June 25 and its 6-week average of 46 according to Track Data, suggesting larger price fluctuations.
|
|
|
|
